Yufei Xiang

2.1k total citations · 1 hit paper
30 papers, 1.4k citations indexed

About

Yufei Xiang is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Yufei Xiang has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 18 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Surgery. Recurrent topics in Yufei Xiang's work include Diabetes and associated disorders (24 papers), Pancreatic function and diabetes (16 papers) and Diabetes Management and Research (13 papers). Yufei Xiang is often cited by papers focused on Diabetes and associated disorders (24 papers), Pancreatic function and diabetes (16 papers) and Diabetes Management and Research (13 papers). Yufei Xiang collaborates with scholars based in China, United States and United Kingdom. Yufei Xiang's co-authors include Zhiguang Zhou, Bingwen Liu, Xuan Guan, Min Li, Gan Huang, Richard David Leslie, Xia Li, Zhenqi Liu, Lin Yang and Shuoming Luo and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yufei Xiang

30 papers receiving 1.4k citations

Hit Papers

Can we use interleukin-6 (IL-6) blockade for coronavirus ... 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
    2020 560 citations Bingwen Liu, Min Li et al. Journal of Autoimmunity profile →

Peers

Yufei Xiang
Juyi Li China
Tjin‐Shing Jap Taiwan
Yanmei Huang China
Eric K. Patterson Canada
Athanasios Vergopoulos Germany
Mayur Garg Australia
Changchun Qiu China
Yun Huang China
Fránco Cerutti Italy
Katherine Barriga United States
Juyi Li China
Yufei Xiang
Citations per year, relative to Yufei Xiang Yufei Xiang (= 1×) peers Juyi Li

Countries citing papers authored by Yufei Xiang

Since Specialization
Citations

This map shows the geographic impact of Yufei Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Xiang more than expected).

Fields of papers citing papers by Yufei Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufei Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Xiang. The network helps show where Yufei Xiang may publish in the future.

Co-authorship network of co-authors of Yufei Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yufei Xiang. A scholar is included among the top collaborators of Yufei Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufei Xiang. Yufei Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Xiang, Xia Li, Bingwen Liu, et al.. (2023). Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial. Signal Transduction and Targeted Therapy. 8(1). 158–158. 11 indexed citations
2.
Tan, Tingting, Yufei Xiang, Chao Deng, et al.. (2022). Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes. Frontiers in Immunology. 13. 974864–974864. 11 indexed citations
3.
Li, Xia, Yufei Xiang, Xiang Yan, et al.. (2022). Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey. Annals of Translational Medicine. 10(16). 851–851. 3 indexed citations
4.
Luo, Shuoming, et al.. (2022). Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin. Frontiers in Immunology. 13. 968798–968798. 14 indexed citations
5.
Li, Xia, Yufei Xiang, Xiang Yan, et al.. (2022). GAD65 Antibody Epitopes and Genetic Background in Latent Autoimmune Diabetes in Youth (LADY). Frontiers in Immunology. 13. 836952–836952. 4 indexed citations
6.
Fan, Wenqi, Xia Li, Yufei Xiang, et al.. (2022). Distribution of autoantibodies to insulinoma‐associated antigen‐2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross‐sectional study. Diabetes/Metabolism Research and Reviews. 39(2). e3592–e3592. 2 indexed citations
7.
Li, Xia, Yufei Xiang, Xiang Yan, et al.. (2021). Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages. Diabetes Technology & Therapeutics. 24(3). 212–219. 6 indexed citations
8.
Liu, Bingwen, Min Li, Zhiguang Zhou, Xuan Guan, & Yufei Xiang. (2020). Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?. Journal of Autoimmunity. 111. 102452–102452. 560 indexed citations breakdown →
9.
Liu, Bingwen, Yufei Xiang, Zhenqi Liu, & Zhiguang Zhou. (2019). Past, present and future of latent autoimmune diabetes in adults. Diabetes/Metabolism Research and Reviews. 36(1). e3205–e3205. 31 indexed citations
10.
Luo, Shuoming, Xia Li, Gan Huang, et al.. (2019). Distinct two different ages associated with clinical profiles of acute onset type 1 diabetes in Chinese patients. Diabetes/Metabolism Research and Reviews. 36(2). e3209–e3209. 12 indexed citations
11.
Deng, Chao, Yufei Xiang, Tingting Tan, et al.. (2017). The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status. Journal of Diabetes Research. 2017. 1–9. 15 indexed citations
12.
Huang, Gan, Min Yin, Yufei Xiang, et al.. (2016). Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3‐year follow‐up. Diabetes/Metabolism Research and Reviews. 32(6). 615–622. 37 indexed citations
13.
Xiang, Yufei, Gan Huang, Zhongyan Shan, et al.. (2015). Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5. Acta Diabetologica. 52(6). 1121–1127. 37 indexed citations
14.
Li, Jingbo, Bing Xiao, & Yufei Xiang. (2014). Immune Function of Vitamin D in Type 1 Diabetes Mellitus. SHILAP Revista de lepidopterología. 4 indexed citations
15.
16.
Liao, Yu, Yufei Xiang, & Zhiguang Zhou. (2012). Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection. Frontiers of Medicine. 6(3). 243–247. 16 indexed citations
17.
Zhou, Zhiguang, Yufei Xiang, Linong Ji, et al.. (2012). Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study). Diabetes. 62(2). 543–550. 202 indexed citations
18.
Wong, F. Susan, Changyun Hu, Yufei Xiang, & Wen Li. (2010). To B or not to B — pathogenic and regulatory B cells in autoimmune diabetes. Current Opinion in Immunology. 22(6). 723–731. 9 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juyi Li Breakdown of academic impact, for papers by Tjin‐Shing Jap Breakdown of academic impact, for papers by Yanmei Huang Breakdown of academic impact, for papers by Eric K. Patterson Breakdown of academic impact, for papers by Athanasios Vergopoulos Breakdown of academic impact, for papers by Mayur Garg Breakdown of academic impact, for papers by Changchun Qiu Breakdown of academic impact, for papers by Yun Huang Breakdown of academic impact, for papers by Fránco Cerutti Breakdown of academic impact, for papers by Katherine Barriga
Rankless by CCL
2026